Compare PTGX & SLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTGX | SLM |
|---|---|---|
| Founded | 2006 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.7B |
| IPO Year | 2016 | N/A |
| Metric | PTGX | SLM |
|---|---|---|
| Price | $89.29 | $30.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $86.44 | $34.31 |
| AVG Volume (30 Days) | 886.1K | ★ 2.2M |
| Earning Date | 11-06-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 1.71% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.72 | ★ 2.84 |
| Revenue | $209,217,000.00 | ★ $1,460,617,000.00 |
| Revenue This Year | N/A | $6.00 |
| Revenue Next Year | $296.47 | $16.24 |
| P/E Ratio | $124.09 | ★ $10.72 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $33.70 | $23.81 |
| 52 Week High | $93.25 | $34.97 |
| Indicator | PTGX | SLM |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 72.45 |
| Support Level | $83.52 | $29.01 |
| Resistance Level | $90.85 | $30.44 |
| Average True Range (ATR) | 2.63 | 0.77 |
| MACD | -0.33 | 0.29 |
| Stochastic Oscillator | 83.62 | 97.64 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
SLM Corp is an education solutions company. It business is to originate and service loans to students and their families to finance the cost of their education. The provide Private Education Loans to mean education loans to students or their families that are not made, insured, or guaranteed by any state or federal government.